Arch joins Celgene, China investors bankrolling a pioneering New York biotech startup focused on a new approach to metastasis
Julio Aguirre-Ghiso has steered the work in his lab at Mount Sinai down some of the less-traveled pathways of cancer research. And it’s led him …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
